ProShare Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-756
| Closed | -$6.88K | – | 1928 |
|
|
2023
Q1 | $6.88K | Sell |
756
-71
| -9% | -$646 | ﹤0.01% | 1775 |
|
|
2022
Q4 | $9.7K | Buy |
827
+119
| +17% | +$1.4K | ﹤0.01% | 1832 |
|
|
2022
Q3 | $15K | Sell |
708
-14
| -2% | -$297 | ﹤0.01% | 1728 |
|
|
2022
Q2 | $17K | Sell |
722
-456
| -39% | -$10.7K | ﹤0.01% | 1776 |
|
|
2022
Q1 | $59K | Sell |
1,178
-194
| -14% | -$9.72K | ﹤0.01% | 2103 |
|
|
2021
Q4 | $97K | Buy |
1,372
+577
| +73% | +$40.8K | ﹤0.01% | 2210 |
|
|
2021
Q3 | $74K | Sell |
795
-815
| -51% | -$75.9K | ﹤0.01% | 1946 |
|
|
2021
Q2 | $162K | Buy |
1,610
+5
| +0.3% | +$503 | ﹤0.01% | 2201 |
|
|
2021
Q1 | $150K | Buy |
1,605
+274
| +21% | +$25.6K | ﹤0.01% | 2107 |
|
|
2020
Q4 | $110K | Buy |
1,331
+629
| +90% | +$52K | ﹤0.01% | 1977 |
|
|
2020
Q3 | $60K | Sell |
702
-76
| -10% | -$6.5K | ﹤0.01% | 1578 |
|
|
2020
Q2 | $72K | Buy |
+778
| New | +$72K | ﹤0.01% | 1607 |
|
|
2020
Q1 | – | Sell |
-692
| Closed | -$29K | – | 1650 |
|
|
2019
Q4 | $29K | Buy |
+692
| New | +$29K | ﹤0.01% | 1769 |
|